Therapeutic Apheresis Market

Market Study on Therapeutic Apheresis: PMR Foresees a Host of Growth Opportunities Ahead for the Market Participants, Analysing the Expanding Application Base, and Advancements in Apheresis Technologies

A Detailed Analysis of the Therapeutic Apheresis Market Based on the Escalating Prevalence of Autoimmune and Hematologic Disorders, and an Increasing Emphasis on Personalized Medicine Approaches

Report ID: PMRREP33788

Number of Pages: 178

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Published Date: January-2024

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary

    1.1. Global Therapeutic Apheresis Market Snapshot, 2023 and 2030

    1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events   

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Challenges

        2.2.5. Key Trends

    2.3. Procedure Types Lifecycle Analysis

    2.4. Therapeutic Apheresis Market: Value Chain

        2.4.1. List of Raw Material Supplier

        2.4.2. List of Manufacturers

        2.4.3. List of Distributors

        2.4.4. List of Applications

        2.4.5. Profitability Analysis

    2.5. Porter Five Force's Analysis

    2.6. Geopolitical Tensions: Market Impact   

    2.7. Macro-Economic Factors

        2.7.1. Global Sectorial Outlook

        2.7.2. Global GDP Growth Outlook

        2.7.3. Global Parent Market Overview

    2.8. Forecast Factors - Relevance and Impact

    2.9. Regulatory and Technology Landscape

3. Global Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    3.1. Key Highlights

        3.1.1. Market Volume (Units) Projections

        3.1.2. Market Size and Y-o-Y Growth

        3.1.3. Absolute $ Opportunity

    3.2. Market Size (US$ Mn) Analysis and Forecast

        3.2.1. Historical Market Size Analysis, 2013-2016

        3.2.2. Current Market Size Forecast, 2018-2026

    3.3. Global Therapeutic Apheresis Market Outlook: Procedure Types

        3.3.1. Introduction / Key Findings

        3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Procedure Types, 2018 - 2022

        3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

            3.3.3.1. Therapeutic Plasma Exchange (TPE)

            3.3.3.2. Red Blood Cell Exchange (RBCX)

            3.3.3.3. Cellular Depletions

    3.4. Market Attractiveness Analysis: Procedure Types

    3.5. Global Therapeutic Apheresis Market Outlook: Technology

        3.5.1. Introduction / Key Findings

        3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technology, 2018 - 2022

        3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

            3.5.3.1. Centrifugation

            3.5.3.2. Membrane filtration

    3.6. Market Attractiveness Analysis: Technology

    3.7. Global Therapeutic Apheresis Market Outlook: Application

        3.7.1. Introduction / Key Findings

        3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022

        3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

            3.7.3.1. Hematology

            3.7.3.2. Neurology

            3.7.3.3. Nephrology

            3.7.3.4. Rheumatology

            3.7.3.5. Oncology

            3.7.3.6. Others

    3.8. Market Attractiveness Analysis: Application

    3.9. Global Therapeutic Apheresis Market Outlook: End User

        3.9.1. Introduction / Key Findings

        3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022

        3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

            3.9.3.1. Hospitals    

            3.9.3.2. Blood banks    

            3.9.3.3. Specialty clinics    

    3.10. Market Attractiveness Analysis: End User

4. Global Therapeutic Apheresis Market Outlook: Region

    4.1. Key Highlights

    4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022

    4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030

        4.3.1. North America

        4.3.2. Europe

        4.3.3. East Asia

        4.3.4. South Asia and Oceania

        4.3.5. Latin America

        4.3.6. Middle East & Africa (MEA)

    4.4. Market Attractiveness Analysis: Region

5. North America Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030) 

    5.1. Key Highlights

    5.2. Pricing Analysis

    5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        5.3.1. By Country

        5.3.2. By Procedure Types

        5.3.3. By Technology

        5.3.4. By Application 

        5.3.5. By End User

    5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        5.4.1. U.S.

        5.4.2. Canada

    5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        5.5.1. Therapeutic Plasma Exchange (TPE)

        5.5.2. Red Blood Cell Exchange (RBCX)

        5.5.3. Cellular Depletions

    5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        5.6.1. Centrifugation

        5.6.2. Membrane filtration

    5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        5.7.1. Hematology

        5.7.2. Neurology

        5.7.3. Nephrology

        5.7.4. Rheumatology

        5.7.5. Oncology

        5.7.6. Others

    5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        5.8.1. Hospitals    

        5.8.2. Blood banks    

        5.8.3. Specialty clinics

    5.9. Market Attractiveness Analysis

6. Europe Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    6.1. Key Highlights

    6.2. Pricing Analysis

    6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        6.3.1. By Country

        6.3.2. By Procedure Types

        6.3.3. By Technology

        6.3.4. By Application 

        6.3.5. By End User

    6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        6.4.1. Germany

        6.4.2. France

        6.4.3. U.K.

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Russia

        6.4.7. Türkiye

        6.4.8. Rest of Europe

    6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        6.5.1. Therapeutic Plasma Exchange (TPE)

        6.5.2. Red Blood Cell Exchange (RBCX)

        6.5.3. Cellular Depletions

    6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        6.6.1. Centrifugation

        6.6.2. Membrane filtration

    6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        6.7.1. Hematology

        6.7.2. Neurology

        6.7.3. Nephrology

        6.7.4. Rheumatology

        6.7.5. Oncology

        6.7.6. Others

    6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        6.8.1. Hospitals    

        6.8.2. Blood banks    

        6.8.3. Specialty clinics

    6.9. Market Attractiveness Analysis

7. East Asia Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    7.1. Key Highlights

    7.2. Pricing Analysis

    7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        7.3.1. By Country

        7.3.2. By Procedure Types

        7.3.3. By Technology

        7.3.4. By Application 

        7.3.5. By End User

    7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        7.4.1. China

        7.4.2. Japan

        7.4.3. South Korea

    7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        7.5.1. Therapeutic Plasma Exchange (TPE)

        7.5.2. Red Blood Cell Exchange (RBCX)

        7.5.3. Cellular Depletions

    7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        7.6.1. Centrifugation

        7.6.2. Membrane filtration

    7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        7.7.1. Hematology

        7.7.2. Neurology

        7.7.3. Nephrology

        7.7.4. Rheumatology

        7.7.5. Oncology

        7.7.6. Others

    7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        7.8.1. Hospitals    

        7.8.2. Blood banks    

        7.8.3. Specialty clinics

    7.9. Market Attractiveness Analysis

8. South Asia & Oceania Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    8.1. Key Highlights

    8.2. Pricing Analysis

    8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        8.3.1. By Country

        8.3.2. By Procedure Types

        8.3.3. By Technology

        8.3.4. By Application 

        8.3.5. By End User

    8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        8.4.1. India

        8.4.2. Southeast Asia

        8.4.3. ANZ

        8.4.4. Rest of South Asia & Oceania

    8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        8.5.1. Therapeutic Plasma Exchange (TPE)

        8.5.2. Red Blood Cell Exchange (RBCX)

        8.5.3. Cellular Depletions

    8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        8.6.1. Centrifugation

        8.6.2. Membrane filtration

    8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        8.7.1. Hematology

        8.7.2. Neurology

        8.7.3. Nephrology

        8.7.4. Rheumatology

        8.7.5. Oncology

        8.7.6. Others

    8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        8.8.1. Hospitals    

        8.8.2. Blood banks    

        8.8.3. Specialty clinics

    8.9. Market Attractiveness Analysis

9. Latin America Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    9.1. Key Highlights

    9.2. Pricing Analysis

    9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        9.3.1. By Country

        9.3.2. By Procedure Types

        9.3.3. By Technology

        9.3.4. By Application 

        9.3.5. By End User

    9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Rest of Latin America

    9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        9.5.1. Therapeutic Plasma Exchange (TPE)

        9.5.2. Red Blood Cell Exchange (RBCX)

        9.5.3. Cellular Depletions

    9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        9.6.1. Centrifugation

        9.6.2. Membrane filtration

    9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        9.7.1. Hematology

        9.7.2. Neurology

        9.7.3. Nephrology

        9.7.4. Rheumatology

        9.7.5. Oncology

        9.7.6. Others

    9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        9.8.1. Hospitals    

        9.8.2. Blood banks    

        9.8.3. Specialty clinics

    9.9. Market Attractiveness Analysis

10. Middle East & Africa Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    10.1. Key Highlights

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        10.3.1. By Country

        10.3.2. By Procedure Types

        10.3.3. By Technology

        10.3.4. By Application 

        10.3.5. By End User

    10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        10.4.1. GCC

        10.4.2. Egypt

        10.4.3. South Africa

        10.4.4. Northern Africa

        10.4.5. Rest of Middle East & Africa

    10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030

        10.5.1. Therapeutic Plasma Exchange (TPE)

        10.5.2. Red Blood Cell Exchange (RBCX)

        10.5.3. Cellular Depletions

    10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030

        10.6.1. Centrifugation

        10.6.2. Membrane filtration

    10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030

        10.7.1. Hematology

        10.7.2. Neurology

        10.7.3. Nephrology

        10.7.4. Rheumatology

        10.7.5. Oncology

        10.7.6. Others

    10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        10.8.1. Hospitals    

        10.8.2. Blood banks    

        10.8.3. Specialty clinics

    10.9. Market Attractiveness Analysis

11. Competition Landscape

    11.1. Market Share Analysis, 2022

    11.2. Market Structure

        11.2.1. Competition Intensity Mapping By Market  

        11.2.2. Competition Dashboard

        11.2.3. Apparent Procedure Types Capacity

    11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        11.3.1. Asahi Kasei Medical Co.

            11.3.1.1. Overview

            11.3.1.2. Segments and Procedure Types

            11.3.1.3. Key Financials

            11.3.1.4. Market Developments

            11.3.1.5. Market Strategy

        11.3.2. Haemonetics Corporation

            11.3.2.1. Overview

            11.3.2.2. Segments and Procedure Types

            11.3.2.3. Key Financials

            11.3.2.4. Market Developments

            11.3.2.5. Market Strategy

        11.3.3. Miltenyi Biotec

            11.3.3.1. Overview

            11.3.3.2. Segments and Procedure Types

            11.3.3.3. Key Financials

            11.3.3.4. Market Developments

            11.3.3.5. Market Strategy

        11.3.4. Cerus Corporation

            11.3.4.1. Overview

            11.3.4.2. Segments and Procedure Types

            11.3.4.3. Key Financials

            11.3.4.4. Market Developments

            11.3.4.5. Market Strategy

        11.3.5. Terumo BCT Inc. 

            11.3.5.1. Overview

            11.3.5.2. Segments and Procedure Types

            11.3.5.3. Key Financials

            11.3.5.4. Market Developments

            11.3.5.5. Market Strategy

        11.3.6. Fresenius Kabi USA

            11.3.6.1. Overview

            11.3.6.2. Segments and Procedure Types

            11.3.6.3. Key Financials

            11.3.6.4. Market Developments

            11.3.6.5. Market Strategy

        11.3.7. Terumo Bct

            11.3.7.1. Overview

            11.3.7.2. Segments and Procedure Types

            11.3.7.3. Key Financials

            11.3.7.4. Market Developments

            11.3.7.5. Market Strategy

        11.3.8. B. Braun Melsungen AG

            11.3.8.1. Overview

            11.3.8.2. Segments and Procedure Types

            11.3.8.3. Key Financials

            11.3.8.4. Market Developments

            11.3.8.5. Market Strategy

        11.3.9. Nikkiso Co. Ltd.

            11.3.9.1. Overview

            11.3.9.2. Segments and Procedure Types

            11.3.9.3. Key Financials

            11.3.9.4. Market Developments

            11.3.9.5. Market Strategy

        11.3.10. Medica S.p.A.

            11.3.10.1. Overview

            11.3.10.2. Segments and Procedure Types

            11.3.10.3. Key Financials

            11.3.10.4. Market Developments

            11.3.10.5. Market Strategy

        11.3.11. Baxter Healthcare Corporation

            11.3.11.1. Overview

            11.3.11.2. Segments and Procedure Types

            11.3.11.3. Key Financials

            11.3.11.4. Market Developments

            11.3.11.5. Market Strategy

        11.3.12. Kawasumi Laboratories Inc.

            11.3.12.1. Overview

            11.3.12.2. Segments and Procedure Types

            11.3.12.3. Key Financials

            11.3.12.4. Market Developments

            11.3.12.5. Market Strategy

        11.3.13. Therakos Incorporation

            11.3.13.1. Overview

            11.3.13.2. Segments and Procedure Types

            11.3.13.3. Key Financials

            11.3.13.4. Market Developments

            11.3.13.5. Market Strategy

12. Appendix

    12.1. Research Methodology

    12.2. Research Assumptions

    12.3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate